Prostatic intraepithelial neoplasia: An update

Clinical Prostate Cancer

Volumn 3, Issue 1, 2004, Pages 26-30

  Cheng, Liang ^a,b   Paterson, Ryan F ^a   Beck, Stephen D W ^a   Parks, Jodi ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Chemoprevention; Needle biopsy; Prognosis; Prostate specific antigen

Indexed keywords

ALPHA TOCOPHEROL; CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN; SELENIUM; VITAMIN D;

ANTIGEN EXPRESSION; CANCER PREVENTION; CARCINOMA IN SITU; CHEMOPROPHYLAXIS; CLINICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PROSTATE CARCINOMA; PROSTATECTOMY; REVIEW;

EID: 3442884218     PISSN: 15400352     EISSN: None     Source Type: Journal    
DOI: 10.3816/CGC.2004.n.009     Document Type: Review

References (47)

1. Bostwick DG, Montironi R. Prostatic intraepithelial neoplasia and the origins of prostatic carcinoma. Pathol Res Pract 1995; 191:828-832.
2. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996; 29:117-134.
3. Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report. Scand J Urol Nephrol Suppl 2000; 3-10.
4. Bostwick DG. Prostatic intraepithelial neoplasia is a risk factor for cancer. Semin Urol Oncol 1999; 17:187-198.
5. Sakr WA. Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention. Eur Urol 1999; 35:474-478.
6. Sakr WA, Partin AW. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia. Urology 2001; 57:115-120.
7. Bostwick DG. High grade prostatic intraepithelial neoplasia. The most likely precursor o prostate cancer. Cancer 1995; 75:1823-1836.
8. Haggman MJ, Adolfsson J, Khoury S, et al. Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract. Scand J Urol Nephrol Suppl 2000; 44-49.
9. Qian J, Wollan P, Bostwick DG. The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol 1997; 28:143-148.
10. Sakr WA, Ward C, Grignon DJ, et al. Epidemiology and molecular biology of early prostatic neoplasia. Mol Urol 2000; 4:109-115.
11. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol 1995; 154:1791-1794.
12. Wills ML, Hamper UM, Partin AW, et al. Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology 1997; 49:367-373.
13. Gaudin PB, Sesterhenn IA, Wojno KJ, et al. Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens. Urology 1997; 49:558-563.
14. Pacelli A, Bostwick DG. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. Urology 1997; 50:355-359.
15. Desai SB, Borges AM. The prevalence of high-grade prostatic intraepithelial neoplasia in surgical resection specimens: an Indian experience. Cancer 2002; 94:2350-2352.
16. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986; 17:64-71.
17. Sakr WA, Grignon DJ, Crissman JD, et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 1994; 8:439-443.
18. Sakr WA, Grignon DJ, Haas GP, et al. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 1996; 30:138-144.
19. Sakr WA, Haas GP, Cassin BF, et al. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993; 150:379-385.
20. Alexander EE, Qian J, Wollan PC, et al. Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration. Urology 1996; 47:693-698.
21. Bostwick DG. Prostatic intraepithelial neoplasia. Curr Urol Rep 2000; 1:65-70.
22. Vis AN, Van Der Kwast TH. Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective. BJU Int 2001; 88:147-157.
23. Lee F, Torp-Pedersen ST, Carroll JT, et al. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia. Urology 1989; 34:4-8.
24. Cheng L, Song SY, Pretlow TG, et al. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Nad Cancer Inst 1998; 90:233-237.
25. Bostwick DG, Shan A, Qian J, et al. Independent origin of multiple foci of prostate intraepithelial neoplasia (PIN): comparison with matched foci of prostate cancer. Cancer 1998; 83:1995-2002.
26. Raviv G, Janssen T, Zlotta AR, et al. Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol 1996; 156:1050-1055.
27. Weinstein MH, Epstein JI. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol 1993; 24:624-629.
28. Brawer MK, Bigler SA, Sohlberg OE, et al. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 1991; 38:103-107.
29. Raviv G, Zlotta AR, Janssen T, et al. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? Cancer 1996; 77:2103-2108.
30. O'Dowd GJ, Miller MC, Orozco R, et al. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000; 55:553-559.
31. Davidson D, Bostwick DG, Qian J, et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 1995; 154:1295-1299.
32. Kronz JD, Allan CH, Shaikh AA, et al. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol 2001; 25:1079-1085.
33. San Francisco IF, Olumi AF, Kao J, et al. Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies. BJU Int 2003; 91:350-354.
34. McNeal JE, Alroy J, Leav I, et al. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol 1988; 90:23-32.
35. Ferguson J, Zincke H, Ellison E, et al. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology 1994; 44:91-95.
36. Balaji KC, Rabbani F, Tsai H, et al. Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance. J Urol 1999; 162:753-757.
37. Bostwick DG, Qian J. Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia. Urology 2001; 58:91-93.
38. Cheng L, Cheville JC, Pisansky TM, et al. Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol 1999; 23:803-808.
39. van der Kwast TH, Labrie F, Tetu B. Prostatic intraepithelial neoplasia and endocrine manipulation. Eur Urol 1999; 35:508-510.
40. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349:215-224.
41. Cote RJ, Skinner EC, Salem CE, et al. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. Br J Cancer 1998; 78:413-418.
42. Sakr WA, Grignon DJ, Srigley J, et al. Recent trends in regarding the significance of isolated high grade prostastic intraepithelial neoplaia "HGPIN" in predicting prostate cancer "PCA" on followup biopsies: is there a change in confirming cancer diagnosois? a multi institutional study. Mod Pathol 2003; 16:168A.
43. Gokden N, Koehl K, Humphrey PA. High-grade prostatic intraepithelial neoplasia in needle biopsy tissue as a risk factor for detection of adenocarcinoma: current level of risk in a screening population. Mod Pathol 2003; 16:152A.
44. Schlesinger C, Bostwick DG. Follow up of high grade prostatic intraepithelial neoplasia and a typical small acinar proliferation in a highly screened patient population. Mod Pathol 2003; 16:169A.
45. Siever J, Oryschak A, Trpkov K. Prostatic intraepithelial neoplasia, high grade (PIN): pathological clinical findings on initial and repeat ten-core biopsy. Mod Pathol 2003; 16:171A.
46. Clark LC, Marshall JR. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia. Urology 2001; 57:186-187.
47. Alberts SR, Blute ML. Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia. Urology 2001; 57:188-190.